HELLO PHARMA

HELLO PHARMA has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €215,008 and a net result of €101,939. Equity is growing by about 22% per year across the filed financial years. Its solvency ranks better than 60% of 613 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).